To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The ASCO Post
A new four-drug therapy called Smart Stop was presented at the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition. Investigators reported this targeted therapy is promising for first-line treatment of diffuse large B-cell lymphoma (DLBCL). Dipenkumar Modi, M.D., hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, reviewed the study and agrees that Smart Stop could be a safe and effective therapeutic approach with positive results over the next year or so.
Read the article here.